Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study

BACKGROUND: Antiseizure medications can have negative effects on plasma lipid levels. OBJECTIVES: To evaluate plasma lipid changes in patients with newly diagnosed focal epilepsy treated with eslicarbazepine acetate (ESL) or controlled-release carbamazepine (CBZ-CR) monotherapy during a phase III, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinka, Eugen, Rocamora, Rodrigo, Chaves, João, Koepp, Mathias J., Rüegg, Stephan, Holtkamp, Martin, Moreira, Joana, Fonseca, Miguel M., Castilla-Fernández, Guillermo, Ikedo, Fábio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478566/
https://www.ncbi.nlm.nih.gov/pubmed/37675038
http://dx.doi.org/10.1177/17562864231193530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478566/
https://www.ncbi.nlm.nih.gov/pubmed/37675038
http://dx.doi.org/10.1177/17562864231193530

Ejemplares similares